Risk factors for dementia diagnosis in German primary care practices

International Psychogeriatrics

Volumn 28, Issue 7, 2016, Pages 1059-1065

  Booker, Anke ^a   Jacob, Louis Ec ^b   Rapp, Michael ^c   Bohlken, Jens ^d   Kostev, Karel ^a  

^a IQVIA   (United States)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITY OF POTSDAM   (Germany)

^d Praxis Bohlken   (Germany)

Author keywords

Alzheimer; dementia; risk factors; statins

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR;

AGE; AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; GERMANY; HEALTH INSURANCE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARKINSON DISEASE; PHYSICIAN; PREDICTION; PRIMARY MEDICAL CARE; RISK FACTOR; RISK REDUCTION; SKULL INJURY; TRANSIENT ISCHEMIC ATTACK; VERY ELDERLY; DEMENTIA ASSESSMENT; PRIMARY HEALTH CARE; PROCEDURES; PROTECTION; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DEMENTIA; FEMALE; GERMANY; HUMANS; MALE; MENTAL STATUS AND DEMENTIA TESTS; PRIMARY HEALTH CARE; PROTECTIVE FACTORS; RISK FACTORS;

EID: 84953738066     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610215002082     Document Type: Article

References (36)

1. Bachman, D. L. et al. (1993). Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham study. Neurology, 43, 515-519.
2. Becher, H., Kostev, K. and Schröder-Bernhardi, D. (2009). Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies. International Journal of Clinical Pharmacology and Therapeutics, 47, 617-626.
3. Busse, A., Bischkopf, J., Riedel-Heller, S. G. and Angermeyer, M. C. (2003). Mild cognitive impairment: Prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal study of the aged (LEILA75+). The British Journal of Psychiatry, 182, 449-454.
4. Corder, E. H. et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
5. Cummings, J. L. (1988). Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates. Journal of Geriatric Psychiatry and Neurology, 1, 24-36.
6. European Brain Council (2012). Parkinson's Disease Fact Sheet. Available at: http://www. europeanbraincouncil. org.
7. Food and Drug Administration (2012). Drug Safety Communication: important safety label changes to cholesterol-lowering statin drugs. Available at: http://www. fda. gov/Drugs/DrugSafety/ucm293101. htm.
8. Gupta, S. and Warner, J. (2008). Alcohol-related dementia: A 21st-century silent epidemic? The British Journal of Psychiatry, 193, 351-353. doi: 10. 1192/bjp. bp. 108. 051425.
9. Haenisch, B. et al. (2015). Risk of dementia in elderly patients with the use of proton pump inhibitors. European Archives of Psychiatry and Clinical Neuroscience, 265, 419-428. doi: 10. 1007/s00406-014-0554-0.
10. Ivan, C. S. et al. (2004). Dementia after stroke: the Framingham study. Stroke A Journal of Cerebral Circulation, 35, 1264-1268. doi: 10. 1161/01. STR. 0000127810. 92616. 78.
11. Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. and Drachman, D. A. (2000). Statins and the risk of dementia. The Lancet, 356, 1627-1631.
12. Johnson, M. L. et al. (2012). Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 8, 437-444. doi: 10. 1016/j. jalz. 2011. 05. 2414.
13. Kukull, W. A. et al. (2002). Dementia and Alzheimer disease incidence: A prospective cohort study. Archives of Neurology, 59, 1737-1746.
14. Leibson, C. L. et al. (1997). Risk of dementia among persons with diabetes mellitus: A population-based cohort study. American Journal of Epidemiology, 145, 301-308.
15. McCullagh, C. D., Craig, D., McIlroy, S. P. and Passmore, A. P. (2001). Risk factors for dementia. Advances in Psychiatric Treatment, 7, 24-31. doi: 10. 1192/apt. 7. 1. 24.
16. Mindham, R. H., Ahmed, S. W. and Clough, C. G. (1982). A controlled study of dementia in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 45, 969-974.
17. Morris, J. C. et al. (2001). Mild cognitive impairment represents early-stage Alzheimer disease. Archives of Neurology, 58, 397-405.
18. Mukamal, K. J., Kuller, L. H., Fitzpatrick, A. L., Longstreth, W. T., Mittleman, M. A. and Siscovick, D. S. (2003). Prospective study of alcohol consumption and risk of dementia in older adults. The Journal of the American Medical Association, 289, 1405-1413.
19. Newman, A. B. et al. (2005). Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular health study cohort. Journal of the American Geriatrics Society, 53, 1101-1107. doi: 10. 1111/j. 1532-5415. 2005. 53360. x.
20. OECD/European Union (2014). Dementia prevalence. In Health at a Glance: Europe 2014. Paris: OECD Publishing.
21. O'Keefe, J. H., Bybee, K. A. and Lavie, C. J. (2007). Alcohol and cardiovascular health: the razor-sharp double-edged sword. Journal of the American College of Cardiology, 50, 1009-1014. doi: 10. 1016/j. jacc. 2007. 04. 089.
22. Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A., Hofman, A. and Breteler, M. M. (1999). Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology, 53, 1937-1942.
23. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303-308.
24. Rajput, A. H., Offord, K. P., Beard, C. M. and Kurland, L. T. (1987). A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology, 37, 226-232.
25. Redberg, R. F. and Katz, M. H., (2012). Healthy men should not take statins. The Journal of the American Medical Association, 307, 1491-1492. doi: 10. 1001/jama. 2012. 423.
26. Richardson, K. et al. (2013). Statins and cognitive function: A systematic review. Annals of Internal Medicine, 159, 688-697. doi: 10. 7326/0003-4819-159-10-201311190-00007.
27. Ritchie, K. and Touchon, J. (2000). Mild cognitive impairment: conceptual basis and current nosological status. The Lancet, 355, 225-228. doi: 10. 1016/S0140-6736(99)06155-3.
28. Samii, A., Nutt, J. G. and Ransom, B. R. (2004). Parkinson's disease. The Lancet, 363, 1783-1793. doi: 10. 1016/S0140-6736(04)16305-8.
29. Song, Y., Nie, H., Xu, Y., Zhang, L. and Wu, Y. (2013). Association of statin use with risk of dementia: A meta-analysis of prospective cohort studies. Geriatrics & Gerontology International, 13, 817-824. doi: 10. 1111/ggi. 12044.
30. Swiger, K. J., Manalac, R. J., Blumenthal, R. S., Blaha, M. J. and Martin, S. S. (2013). Statins and cognition: A systematic review and meta-analysis of short-and long-term cognitive effects. Mayo Clinic Proceedings, 88, 1213-1221. doi: 10. 1016/j. mayocp. 2013. 07. 013.
31. Taylor, F. et al. (2013). Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, 1, CD004816. doi: 10. 1002/14651858. CD004816. pub5.
32. WHO (2015). Definition and Statistics on Dementia, Available at: http://www. who. int/features/factfiles/dementia/ dementia-facts/en/; last accessed 9 July 2015.
33. Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G. G. and Siegel, G. (2000). Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Archives of Neurology, 57, 1439-1443.
34. Wong, W. B., Lin, V. W., Boudreau, D. and Devine, E. B. (2013). Statins in the prevention of dementia and Alzheimer's disease: A meta-analysis of observational studies and an assessment of confounding. Pharmacoepidemiology and Drug Safety, 22, 345-358. doi: 10. 1002/pds. 3381.
35. Yoshitake, T. et al. (1995). Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology, 45, 1161-1168.
36. Zhou, B., Teramukai, S. and Fukushima, M. (2007). Prevention and treatment of dementia or Alzheimer's disease by statins: A meta-analysis. Dementia and Geriatric Cognitive Disorders, 23, 194-201. doi: 10. 1159/000099037.